These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 13826091

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Iproniazid and combined iproniazid-reserpine treatment of depressive and inactive patients.
    RASMUSSEN EB, KRISTJANSEN P.
    Acta Psychiatr Scand Suppl; 1959; 34(136):98-100. PubMed ID: 14436356
    [No Abstract] [Full Text] [Related]

  • 4. [Iproniazid (Marsilid) in the treatment of benign hypertension not responding to reserpine].
    TISZAI A.
    Acta Med Acad Sci Hung; 1961; 17():345-53. PubMed ID: 13921386
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical experiences with iproniazid and additional monoamine oxidase inhibitors with analogous effects].
    VOELKEL A.
    Psychiatr Neurol (Basel); 1960 Jul; 140():83-8. PubMed ID: 13781777
    [No Abstract] [Full Text] [Related]

  • 6. [Therapy of psychic diseases with iproniazid (marsilid)].
    SCHAEPPERLE O.
    Nervenarzt; 1959 Dec 20; 30():557-61. PubMed ID: 14442364
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of maniacal states by reserpine-thiopropemazine (RP-7843) association].
    LANTER R, HEINRICH JP.
    Ann Med Psychol (Paris); 1960 Jul 20; 118(2)():341-7. PubMed ID: 14414058
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Combined iproniazid-reserpine treatment-a placebo experiment].
    MYSCHETZKY A, RASMUSSEN EB, HASLUND J.
    Psychiatr Neurol (Basel); 1960 Jul 20; 140():20-2. PubMed ID: 13727276
    [No Abstract] [Full Text] [Related]

  • 12. The use of marsilid in the treatment of mental disorders resistive to previous therapy.
    BREITNER C.
    Ariz Med; 1959 Nov 20; 16():732-5. PubMed ID: 13804145
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical effects of Marsilid and its EEG evaluation].
    KRONBERGEROVA J, JANIK A.
    Act Nerv Super (Praha); 1962 Nov 20; 4():229. PubMed ID: 14459822
    [No Abstract] [Full Text] [Related]

  • 14. [Experiences with combined propaphenine-resedine high dosage therapy of schizophrenic psychoses].
    KRAUSE G.
    Dtsch Gesundheitsw; 1961 Apr 13; 16():684-6. PubMed ID: 13754082
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Pentazole-neuroleptic and neuroleptic treatment of acute schizophrenic psychoses in a catamnestic comparison].
    NAHUNEK K.
    Psychiatr Neurol (Basel); 1961 Apr 13; 142():188-97. PubMed ID: 14478001
    [No Abstract] [Full Text] [Related]

  • 19. Use of reserpine (serpasil) in psychotic patients; a preliminary report.
    WEISHAUS J.
    Dis Nerv Syst; 1955 Nov 13; 16(11):347-50. PubMed ID: 13270677
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.